Telehealth sees rising off-label use of GLP-1s for substance abuse
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag…
Launch price of new medicines dropped very slightly in 2025
Amid ongoing angst over prescription drug prices, a new analysis found the median net price for 202 newly…
Takeaways from an evaluation of Google’s diagnostic chatbot, AMIE – STAT
Takeaways from an evaluation of Google’s diagnostic chatbot, AMIE STATClinical Trial Indicates A.I. Chatbots Could Aid Urgent Care The New…
Why this startup is taking its AI to predict breast-cancer risk directly to patients
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag…
Optogenetics restores some vision in small study
Annalisa (Nalis) Merelli is focused on boys’ and men’s health: She looks into reproductive health, trending treatments, screening…
Merck discontinues antiobiotic Recarbrio in U.S., despite superbug fears
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
Health insurance premiums skyrocket, an unusual hospital deal
Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare…
Pharmalittle: GLP-1s seen as lifestyle drugs; Merck, Daiichi setback
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating.…
In radiology, AI blurs the line between tech development and clinical practice
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag…
Medicare to expand pilot that pays for technology to manage chronic diseases
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech;…
Medicare’s AI prior authorization pilot was rushed, new documents reveal
Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits, or might be…
Gifts from pharma companies keep on giving, a new study finds
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…